MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression |
Zhang, Nan
(Department of Hematology, The General Hospital of Western Theater Command)
Qiu, Ling (Department of Hematology, The General Hospital of Western Theater Command) Li, Tao (Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Army Medical University) Wang, Xiao (Department of Hematology, The General Hospital of Western Theater Command) Deng, Rui (Department of Hematology, The General Hospital of Western Theater Command) Yi, Hai (Department of Hematology, The General Hospital of Western Theater Command) Su, Yi (Department of Hematology, The General Hospital of Western Theater Command) Fan, Fang-yi (Department of Hematology, The General Hospital of Western Theater Command) |
1 | Sermer D, Pasqualucci L, Wendel HG, Melnick A and Younes A (2019) Emerging epigenetic-modulating therapies in lymphoma. Nat Rev Clin Oncol 16, 494-507 DOI |
2 | Shi Y, Dong M, Hong X et al (2015) Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Ann Oncol 26, 1766-1771 DOI |
3 | Ji MM, Huang YH, Huang JY et al (2018) Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified. Haematologica 103, 679-687 DOI |
4 | Van Arnam JS, Lim MS and Elenitoba-Johnson KSJ (2018) Novel insights into the pathogenesis of T-cell lymphomas. Blood 131, 2320-2330 DOI |
5 | Pfister AS (2019) Emerging Role of the Nucleolar Stress Response in Autophagy. Front Cell Neurosci 13, 156 DOI |
6 | Yan J, Zhang J, Zhang X et al (2018) AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma. Mol Med 24, 35 |
7 | Poillet-Perez L and White E (2019) Role of tumor and host autophagy in cancer metabolism. Genes Dev 33, 610-619 DOI |
8 | Zhang H and McCarty N (2017) Tampering with cancer chemoresistance by targeting the TGM2-IL6-autophagy regulatory network. Autophagy 13, 627-628 DOI |
9 | Li Y, Zhou X, Zhang Y et al (2019) CUL4B regulates autophagy via JNK signaling in diffuse large B-cell lymphoma. Cell Cycle 18, 379-394 DOI |
10 | Treiber T, Treiber N and Meister G (2019) Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 20, 5-20 DOI |
11 | Gebert LFR and MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20, 21-37 DOI |
12 | Yao Y, Ma J, Xue Y et al (2015) MiR-449a exerts tumorsuppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein. Mol Oncol 9, 640-656 DOI |
13 | Sandbothe M, Buurman R, Reich N et al (2017) The microRNA-449 family inhibits TGF-beta-mediated liver cancer cell migration by targeting SOX4. J Hepatol 66, 1012-1021 DOI |
14 | Li F, Liang J and Bai L (2018) MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomed Pharmacother 103, 782-789 DOI |
15 | Sun AG, Meng FG and Wang MG (2017) CISD2 promotes the proliferation of glioma cells via suppressing beclin1mediated autophagy and is targeted by microRNA449a. Mol Med Rep 16, 7939-7948 DOI |
16 | Argnani L, Broccoli A and Zinzani PL (2017) Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease. Cancer Treat Rev 61, 61-69 DOI |
17 | Cai Y, Jiang C, Zhu J et al (2019) miR-449a inhibits cell proliferation, migration, and inflammation by regulating high-mobility group box protein 1 and forms a mutual inhibition loop with Yin Yang 1 in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Res Ther 21, 134 DOI |
18 | Swerdlow SH, Campo E, Pileri SA et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375-2390 DOI |
19 | Sorigue M and Sancho JM (2019) Recent landmark studies in follicular lymphoma. Blood Rev 35, 68-80 DOI |
20 | Horwitz S, O'Connor OA, Pro B et al (2019) Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet 393, 229-240 DOI |
21 | Zhang L, Li J, Ouyang L, Liu B and Cheng Y (2016) Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy. Cancer Lett 373, 19-26 DOI |
22 | Fu Y, Huang Z, Hong L et al (2019) Targeting ATG4 in Cancer Therapy. Cancers (Basel) 11, 649 DOI |
23 | Kurdi A, Cleenewerck M, Vangestel C et al (2017) ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice. Biochem Pharmacol 138, 150-162 DOI |
24 | Yao L, Zhu Z, Wu J et al (2019) MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease. FASEB J 33, 8648-8665 DOI |
25 | Akin D, Wang SK, Habibzadegah-Tari P et al (2014) A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors. Autophagy 10, 2021-2035 DOI |
26 | Huang T, Kim CK, Alvarez AA et al (2017) MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell 32, 840-855.e848 DOI |
27 | Zhang N, Wu Y, Lyu X et al (2017) HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells. Cancer Lett 409, 81-90 DOI |
28 | Sun W, Yi Y, Xia G et al (2019) Nrf2-miR-129-3p-mTOR Axis Controls an miRNA Regulatory Network Involved in HDACi-Induced Autophagy. Mol Ther 27, 1039-1050 DOI |
29 | Xu J, Su Y, Xu A et al (2019) miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma. Mol Ther 27, 559-570 DOI |
30 | Qu A, Sun M, Xu L et al (2019) Quantitative zeptomolar imaging of miRNA cancer markers with nanoparticle assemblies. Proc Natl Acad Sci U S A 116, 3391-3400 DOI |
31 | Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V and Mansoori Derakhshan S (2019) A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. J Cell Physiol 234, 19199-19211 DOI |
32 | Asano N, Matsuzaki J, Ichikawa M et al (2019) A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. Nat Commun 10, 1299 DOI |
![]() |